Coherent Launches ACE FL, an All-New, Two-Micron Fiber Laser to Address the Expanding Opportunities in Urology and Other Medical Markets

Core Viewpoint - Coherent Corp. has launched the ACE FL series, a thulium fiber laser designed for therapeutic medical applications, particularly for lithotripsy and benign prostatic hyperplasia (BPH) treatment [1][2]. Group 1: Product Features and Benefits - The ACE FL system offers superior precision, improved patient outcomes, and enhanced procedural efficiency compared to traditional laser technologies like holmium:YAG systems [2]. - Thulium fiber lasers provide superior cutting precision in BPH enucleation, a compact form factor for OEM integration, and enhanced energy efficiency through lower power consumption and improved thermal management [3]. Group 2: Market Position and Opportunities - The shift towards outpatient and minimally invasive procedures creates a strong market opportunity for fiber-based surgical lasers [3]. - Coherent's ACE FL platform utilizes proprietary fiber designs and manufacturing capabilities, offering OEM partners a scalable, high-performance solution for next-generation surgical tools [4]. Group 3: Manufacturing and Innovation - Coherent's vertically integrated manufacturing and IP-protected fiber designs position the company to support global medical device manufacturers with reliable supply and long-term innovation [5]. - The ACE FL series will be showcased at LASER World of Photonics Munich 2025, highlighting the company's commitment to innovation in the photonics industry [5].